Balance between senescence and apoptosis is regulated by telomere damage–induced association between p16 and caspase-3

Shanmugam Panneer Selvam, Braden M. Roth, Rose Nganga, Jisun Kim, Marion Anne Cooley, Kristi Helke, Charles D. Smith, Besim Ogretmen

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Telomerase activation protects cells from telomere damage by delaying senescence and inducing cell immortalization, whereas telomerase inhibition mediates rapid senescence or apoptosis. However, the cellular mechanisms that determine telomere damage– dependent senescence versus apoptosis induction are largely unknown. Here, we demonstrate that telomerase instability mediated by silencing of sphingosine kinase 2 (SPHK2) and sphingosine 1-phosphate (S1P), which binds and stabilizes telomerase, induces telomere damage– dependent caspase-3 activation and apoptosis, but not senescence, in p16-deficient lung cancer cells or tumors. These outcomes were prevented by knockdown of a tumor-suppressor protein, transcription factor 21 (TCF21), or by ectopic expression of WT human telomerase reverse transcriptase (hTERT) but not mutant hTERT with altered S1P binding. Interestingly, SphK2-deficient mice exhibited accelerated aging and telomerase instability that increased telomere damage and senescence via p16 activation especially in testes tissues, but not in apoptosis. Moreover, p16 silencing in SphK2/ mouse embryonic fibroblasts activated caspase-3 and apoptosis without inducing senescence. Furthermore, ectopic WT p16 expression in p16-deficient A549 lung cancer cells prevented TCF21 and caspase-3 activation and resulted in senescence in response to SphK2/S1P inhibition and telomere damage. Mechanistically, a p16 mutant with impaired caspase-3 association did not prevent telomere damage–induced apoptosis, indicating that an association between p16 and caspase-3 proteins forces senescence induction by inhibiting caspase-3 activation and apoptosis. These results suggest that p16 plays a direct role in telomere damage– dependent senescence by limiting apoptosis via binding to caspase-3, revealing a direct link between telomere damage– dependent senescence and apoptosis with regards to aging and cancer.

Original languageEnglish (US)
Pages (from-to)9784-9800
Number of pages17
JournalJournal of Biological Chemistry
Volume293
Issue number25
DOIs
StatePublished - Jan 1 2018

Fingerprint

Telomere
Caspase 3
Association reactions
Apoptosis
Telomerase
Chemical activation
Lung Neoplasms
Transcription Factors
Aging of materials
Cells
Tumor Suppressor Proteins
Cell Aging
Fibroblasts
Testis
Tumors
Neoplasms
Tissue

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Balance between senescence and apoptosis is regulated by telomere damage–induced association between p16 and caspase-3. / Selvam, Shanmugam Panneer; Roth, Braden M.; Nganga, Rose; Kim, Jisun; Cooley, Marion Anne; Helke, Kristi; Smith, Charles D.; Ogretmen, Besim.

In: Journal of Biological Chemistry, Vol. 293, No. 25, 01.01.2018, p. 9784-9800.

Research output: Contribution to journalArticle

Selvam, Shanmugam Panneer ; Roth, Braden M. ; Nganga, Rose ; Kim, Jisun ; Cooley, Marion Anne ; Helke, Kristi ; Smith, Charles D. ; Ogretmen, Besim. / Balance between senescence and apoptosis is regulated by telomere damage–induced association between p16 and caspase-3. In: Journal of Biological Chemistry. 2018 ; Vol. 293, No. 25. pp. 9784-9800.
@article{cb884b959dd848c6bf33bfefbd57de3b,
title = "Balance between senescence and apoptosis is regulated by telomere damage–induced association between p16 and caspase-3",
abstract = "Telomerase activation protects cells from telomere damage by delaying senescence and inducing cell immortalization, whereas telomerase inhibition mediates rapid senescence or apoptosis. However, the cellular mechanisms that determine telomere damage– dependent senescence versus apoptosis induction are largely unknown. Here, we demonstrate that telomerase instability mediated by silencing of sphingosine kinase 2 (SPHK2) and sphingosine 1-phosphate (S1P), which binds and stabilizes telomerase, induces telomere damage– dependent caspase-3 activation and apoptosis, but not senescence, in p16-deficient lung cancer cells or tumors. These outcomes were prevented by knockdown of a tumor-suppressor protein, transcription factor 21 (TCF21), or by ectopic expression of WT human telomerase reverse transcriptase (hTERT) but not mutant hTERT with altered S1P binding. Interestingly, SphK2-deficient mice exhibited accelerated aging and telomerase instability that increased telomere damage and senescence via p16 activation especially in testes tissues, but not in apoptosis. Moreover, p16 silencing in SphK2/ mouse embryonic fibroblasts activated caspase-3 and apoptosis without inducing senescence. Furthermore, ectopic WT p16 expression in p16-deficient A549 lung cancer cells prevented TCF21 and caspase-3 activation and resulted in senescence in response to SphK2/S1P inhibition and telomere damage. Mechanistically, a p16 mutant with impaired caspase-3 association did not prevent telomere damage–induced apoptosis, indicating that an association between p16 and caspase-3 proteins forces senescence induction by inhibiting caspase-3 activation and apoptosis. These results suggest that p16 plays a direct role in telomere damage– dependent senescence by limiting apoptosis via binding to caspase-3, revealing a direct link between telomere damage– dependent senescence and apoptosis with regards to aging and cancer.",
author = "Selvam, {Shanmugam Panneer} and Roth, {Braden M.} and Rose Nganga and Jisun Kim and Cooley, {Marion Anne} and Kristi Helke and Smith, {Charles D.} and Besim Ogretmen",
year = "2018",
month = "1",
day = "1",
doi = "10.1074/jbc.RA118.003506",
language = "English (US)",
volume = "293",
pages = "9784--9800",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "25",

}

TY - JOUR

T1 - Balance between senescence and apoptosis is regulated by telomere damage–induced association between p16 and caspase-3

AU - Selvam, Shanmugam Panneer

AU - Roth, Braden M.

AU - Nganga, Rose

AU - Kim, Jisun

AU - Cooley, Marion Anne

AU - Helke, Kristi

AU - Smith, Charles D.

AU - Ogretmen, Besim

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Telomerase activation protects cells from telomere damage by delaying senescence and inducing cell immortalization, whereas telomerase inhibition mediates rapid senescence or apoptosis. However, the cellular mechanisms that determine telomere damage– dependent senescence versus apoptosis induction are largely unknown. Here, we demonstrate that telomerase instability mediated by silencing of sphingosine kinase 2 (SPHK2) and sphingosine 1-phosphate (S1P), which binds and stabilizes telomerase, induces telomere damage– dependent caspase-3 activation and apoptosis, but not senescence, in p16-deficient lung cancer cells or tumors. These outcomes were prevented by knockdown of a tumor-suppressor protein, transcription factor 21 (TCF21), or by ectopic expression of WT human telomerase reverse transcriptase (hTERT) but not mutant hTERT with altered S1P binding. Interestingly, SphK2-deficient mice exhibited accelerated aging and telomerase instability that increased telomere damage and senescence via p16 activation especially in testes tissues, but not in apoptosis. Moreover, p16 silencing in SphK2/ mouse embryonic fibroblasts activated caspase-3 and apoptosis without inducing senescence. Furthermore, ectopic WT p16 expression in p16-deficient A549 lung cancer cells prevented TCF21 and caspase-3 activation and resulted in senescence in response to SphK2/S1P inhibition and telomere damage. Mechanistically, a p16 mutant with impaired caspase-3 association did not prevent telomere damage–induced apoptosis, indicating that an association between p16 and caspase-3 proteins forces senescence induction by inhibiting caspase-3 activation and apoptosis. These results suggest that p16 plays a direct role in telomere damage– dependent senescence by limiting apoptosis via binding to caspase-3, revealing a direct link between telomere damage– dependent senescence and apoptosis with regards to aging and cancer.

AB - Telomerase activation protects cells from telomere damage by delaying senescence and inducing cell immortalization, whereas telomerase inhibition mediates rapid senescence or apoptosis. However, the cellular mechanisms that determine telomere damage– dependent senescence versus apoptosis induction are largely unknown. Here, we demonstrate that telomerase instability mediated by silencing of sphingosine kinase 2 (SPHK2) and sphingosine 1-phosphate (S1P), which binds and stabilizes telomerase, induces telomere damage– dependent caspase-3 activation and apoptosis, but not senescence, in p16-deficient lung cancer cells or tumors. These outcomes were prevented by knockdown of a tumor-suppressor protein, transcription factor 21 (TCF21), or by ectopic expression of WT human telomerase reverse transcriptase (hTERT) but not mutant hTERT with altered S1P binding. Interestingly, SphK2-deficient mice exhibited accelerated aging and telomerase instability that increased telomere damage and senescence via p16 activation especially in testes tissues, but not in apoptosis. Moreover, p16 silencing in SphK2/ mouse embryonic fibroblasts activated caspase-3 and apoptosis without inducing senescence. Furthermore, ectopic WT p16 expression in p16-deficient A549 lung cancer cells prevented TCF21 and caspase-3 activation and resulted in senescence in response to SphK2/S1P inhibition and telomere damage. Mechanistically, a p16 mutant with impaired caspase-3 association did not prevent telomere damage–induced apoptosis, indicating that an association between p16 and caspase-3 proteins forces senescence induction by inhibiting caspase-3 activation and apoptosis. These results suggest that p16 plays a direct role in telomere damage– dependent senescence by limiting apoptosis via binding to caspase-3, revealing a direct link between telomere damage– dependent senescence and apoptosis with regards to aging and cancer.

UR - http://www.scopus.com/inward/record.url?scp=85048974807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048974807&partnerID=8YFLogxK

U2 - 10.1074/jbc.RA118.003506

DO - 10.1074/jbc.RA118.003506

M3 - Article

VL - 293

SP - 9784

EP - 9800

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 25

ER -